A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
Clinical trial NCT02604485 · COMPLETED
Trial details
- NCT number
- NCT02604485
- Sponsor
- XOMA (US) LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.